Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Vitae Pharmaceuticals, Inc
| Metric | Vitae Pharmaceuticals, Inc Healthcare |
|---|---|
| Quality Score | 22 / 100 |
| Revenue (latest) | $150,000 |
| Net income (latest) | −$10M |
| Operating margin | −29526.7% |
| Net margin | −6471.3% |
| Return on equity | −17.8% |
| Return on assets | −15.7% |
| Return on capital (ROCE) | −81.2% |
| Debt / equity | 0.14× |
| Revenue growth (YoY) | −87.2% |
| Altman Z″ (distress) | -0.52 |
| Accruals / assets | 45.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.